Rituximab Combining Bortezomib Versus Rituximab in Management of ITP

Clinical trial NCT03443570 · UNKNOWN

Trial details

NCT number: NCT03443570
Sponsor: Shandong University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Immune Thrombocytopenia Purpura, Thrombocytopenic, Idiopathic

Start date: 2018-03-01
Primary completion: 2020-03-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.